Posts by tag
oncodaily
Microbiota-Derived Bile Acids as Androgen Receptor Antagonists Enhance Anti-Tumour Immunity
The gut microbiota can transform cholesterol-derived bile acids into metabolites capable of blocking androgen receptors and strengthening anti-cancer immunity. The study, published in Cell, April 15, demonstrates how one of the microbiota-derived secondary bile acids is capable of suppressing tumour…
Adrian Gottschalk: Making a Difference for His Fellow Human Beings
I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…
Matti Aapro: An Oncologist Who Needs No Introduction
If you have ever stepped into a major oncology congress, you’ve likely felt his presence before you saw him. His voice, distinct and commanding, cuts through a room not with volume, but with purpose. His laugh, genuine and disarming, puts…